ArticleJournal of medicinal chemistry2019
Discovery of MD-224 as a First-in-Class, Highly Potent, and Efficacious Proteolysis Targeting Chimera Murine Double Minute 2 Degrader Capable of Achieving Complete and Durable Tumor Regression.
Yangbing Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
134 papers cite itlatest 60 shown
this paperpooled itcites it